Roche, Novartis slam Italian cartel fine

Save

Novartis accused the Italian antitrust watchdog of flouting European and Italian regulations by openly encouraging widespread use of Avastin (bevacizumab), an anti-VEGF oncology product for use in eye conditions for which it hasn't been licensed, and…